1. Abedi-Gaballu F, Dehghan G, Ghaffari M, Yekta R, Abbaspour-Ravasjani S, Baradaran B, Dolatabadi JEN, Hamblin MR (2018) PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy. Appl Mater Today 12:177–190. https://doi.org/10.1016/j.apmt.2018.05.002
2. Alirezapour B, Hadad Dabaghi H, Ansari Ramandi H, Ghamoushi Ramandi A, Hashemizadeh M, Maadi E, Jalilian A, Rajabifar S, Moradkhani S, Masoumi H, Rahiminejad A (2016a) Radiolabeling and quality control of In-111-CHX-A-DTPA-trastuzumab for radioimmunoscintigraphy. Eur J Nucl Med Mol Imaging 43:S461–S461
3. Alirezapour B, Hadad Dabaghi H, Ghamoushi Ramandi A, Ansari Ramandi H, Soltani N, Hashemizadeh M, Bolorinovin F, Aslan G, Ashtari P (2016b) Radiolabeling and quality control of Ga-67-DTPA-cetuximab for radioimmunoscintigraphy. Eur J Nucl Med Mol Imaging 43:S463–S463
4. Ayati A, Moghimi S, Salarinejad S, Safavi M, Pouramiri B, Foroumadi A (2020) A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy. Bioorg Chem 99:103811. https://doi.org/10.1016/j.bioorg.2020.103811
5. Ayyappan S, Prabhakar D, Sharma N (2013) Epidermal growth factor receptor (EGFR)-targeted therapies in esophagogastric cancer. Anticancer Res 33:4139–4155